D2cm³/DICRU ratio as a surrogate of bladder hotspots localizations during image-guided adaptive brachytherapy for cervical cancer: assessment and implications in late urinary morbidity analysis.

@article{Mazeron2015D2cmDICRURA,
  title={D2cm³/DICRU ratio as a surrogate of bladder hotspots localizations during image-guided adaptive brachytherapy for cervical cancer: assessment and implications in late urinary morbidity analysis.},
  author={Renaud Mazeron and Isabelle Dumas and Eleonor Rivin and Valentine Martin and Wassila Benhabib-Boukhelif and Anne Tailleur and Alain Guemnie-Tafo and Florent Martinetti and Cyrus Chargari and Dimitri Lefkopoulos and Christine Haie-meder},
  journal={Brachytherapy},
  year={2015},
  volume={14 2},
  pages={300-7}
}
PURPOSE To evaluate the efficiency and potential implications of the lowest dose evaluated in the maximally exposed 2cm(3) of the bladder/dose evaluated at the International Commission for Radiation Units and Measurements (ICRU) bladder point (D2cm(3)/DICRU) ratio as surrogate to locate the D2cm(3) in patients treated with MRI-guided adaptive brachytherapy for cervical cancer. METHODS AND MATERIALS The D2cm(3) area of the bladder was located in 69 patients, using the Digital Imaging and… CONTINUE READING